首页> 外国专利> Plural origin of plant origin Biologically active substance

Plural origin of plant origin Biologically active substance

机译:植物来源的多重来源生物活性物质

摘要

The present invention relates to pharmacology and can be used for the preparation of a medicament for viral induced immunodeficiency, as well as for the treatment and prevention of viral diseases such as herpes virus, influenza, B and C hepatitis viruses and the like. Biologically active substances of pharmacological action extracted from the green parts of the genus Gramineae, Calamagrostis Adans and / or the genus Deshampsia Beauv and the small spines are selected from the group consisting of flavonoids, tricine flavonoid aglycones, apigenin, luteolin, quercetin, lanazin and / , Apigenin, luteolin, quercetin, lanazin, adjuvant and the like, and has the following composition: 0.016 to 2062% tricine flavonoid aglycon and / or flavonoid glycoside; 0.010-1393% aglycone flavonoid apigenin and / or its flavonoid glycosides; 0.01 to 4,979% aglycone flavonoid luteolin and / or its flavonoid glycoside; 0,001 to 0,771% quercetin flavonoid aglycone and / or its flavonoid glycoside; 0,104 to 0,203% aglycone flavonoid lanagazine and / or its flavonoid glycosides; 99,868 to 90,592%. Thus, determining the physico-chemical specific composition of the biologically active material and active material to improve the biologically active material results in the production of the optimal composition for viral antitumor activity against the virus and the determination of the dosage (Fig. 1). In addition, biologically active substance was judged to be an inducer of (γ) type, and it was found that it has an effect of regulating apoptosis and has an antioxidant property and increases cell resistance to free radical stress. There is an antiviral action against specific viruses such as type 2 herpes, influenza virus, and hepatitis C virus.
机译:本发明涉及药理学,可用于制备用于病毒诱导的免疫缺陷的药物,以及用于治疗和预防病毒疾病,例如疱疹病毒,流行性感冒,B和C型肝炎病毒等。从禾本科,卡拉马斯藤属和/或Deshampsia Beauv属的绿色部分和小刺中提取的具有药理作用的生物活性物质,选自黄酮类,三黄酮类黄酮苷元,芹菜素,木犀草素,槲皮素,羊毛脂和,芹菜素,木犀草素,槲皮素,羊毛素,佐剂等,具有以下组成:0.016〜2062%的三嗪类黄酮苷元和/或类黄酮苷。 0.010-1393%苷元黄酮芹菜素和/或其类黄酮糖苷; 0.01至4,979%的苷元黄酮类木犀草素和/或其类黄酮糖苷; 0,001至0,771%槲皮素类黄酮苷元和/或其类黄酮苷; 0,104至0,203%的苷元类黄酮Lanagazine和/或其类黄酮糖苷; 99,868至90,592%。因此,确定生物活性材料和活性材料的物理化学特异性组成以改善生物活性材料导致产生用于抗病毒的病毒抗肿瘤活性的最佳组合物并确定剂量(图1)。另外,认为生物活性物质是(γ)型的诱导物,并且发现其具有调节细胞凋亡的作用并且具有抗氧化性质并且增加了细胞对自由基胁迫的抵抗力。对特定病毒(例如2型疱疹,流感病毒和丙型肝炎病毒)有抗病毒作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号